CBD is listed on the Controlled Drug Register in Australia, meaning that it cannot be sold as a consumer product. The Therapeutic Goods Administration (TGA) has announced its interim decision to enable access to CBD products through pharmacies, but without practitioners’ oversight, from 1st June 2021. This report provides a detailed summary of the current regulatory regime in Australia for CBD, covering everything from the hemp plant itself to import/export laws, CBD extracts and finished products, and medical and recreational cannabis.
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.